Divis Laboratories Ltd | DIVI - Operating Profit

Stock Price
5,968.50
Daily Change
-33.50 -0.56%
Monthly
-6.21%
Yearly
1.43%
Q1 Forecast
5,937.24

Divis Laboratories Ltd reported INR7.75B in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Aurobindo Pharma INR 12.49B 511.9M Sep/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.75B 1.58B Sep/2025
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
Lupin INR 18.21B 4.78B Sep/2025
Moderna USD -260M 647M Sep/2025
Organon & Co USD 388M 62M Sep/2025
Revvity USD 98.34M 8.63M Sep/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025